Oxbridge Re (NASDAQ:OXBR) Posts Earnings Results, Misses Estimates By $0.01 EPS

Oxbridge Re (NASDAQ:OXBR) announced its earnings results on Thursday. The insurance provider reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.01), FiscalAI reports. Oxbridge Re had a negative net margin of 76.47% and a negative return on equity of 33.33%. The business had revenue of $0.94 million for the quarter, compared to the consensus estimate of $1.10 million.

Here are the key takeaways from Oxbridge Re’s conference call:

• Oxbridge returned to profitability, reporting second-quarter net income of $176,000, or $0.02 per share, versus a $1.87 million loss in the prior-year quarter. The improvement was driven by no underwriting losses, higher SurancePlus management-fee income, and lower professional fees and compensation.
• SurancePlus expanded beyond Oxbridge-originated reinsurance by closing five tokenized offerings, including three third-party opportunities from HCI Group and Fortex Re, raising $7.1 million in aggregate gross proceeds. Prior-year offerings exceeded their targeted annual returns, although the newer return targets assume no underwriting losses.
• Net premiums earned declined to $368,000 in the quarter and $924,000 for the first six months, versus $582,000 and $1.1 million, respectively, a result of lower weighted-average rates and less capital deployed into reinsurance contracts.
• Oxbridge launched AI GridWorks to develop, own, and operate 10- to 100-megawatt AI data centers, initially targeting the southeastern U.S. The company sees multiple monetization and financing options—including selling entitled, powered land, leasing data-center capacity, operating facilities, and eventually tokenizing interests—but the initiative remains in the development stage.
• Restricted cash and cash equivalents increased to $19.82 million as of June 30, 2026, from $6.98 million at year-end 2025, reflecting new tokenized-security investments, released collateral, and premium deposits.

Oxbridge Re Price Performance

NASDAQ:OXBR traded up $0.11 on Thursday, reaching $1.30. 1,044,618 shares of the company’s stock traded hands, compared to its average volume of 22,731. The stock has a 50-day simple moving average of $1.26 and a 200-day simple moving average of $1.07. Oxbridge Re has a 12 month low of $0.66 and a 12 month high of $2.86. The firm has a market cap of $10.53 million, a PE ratio of -5.20 and a beta of 1.94. The company has a quick ratio of 8.15, a current ratio of 8.15 and a debt-to-equity ratio of 0.16.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Oxbridge Re stock. Virtu Financial LLC acquired a new position in Oxbridge Re Holdings Limited (NASDAQ:OXBR) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 17,789 shares of the insurance provider’s stock, valued at approximately $32,000. Virtu Financial LLC owned about 0.23% of Oxbridge Re at the end of the most recent reporting period. Institutional investors and hedge funds own 5.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Weiss Ratings raised shares of Oxbridge Re from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, July 28th. Zacks Research upgraded Oxbridge Re to a “hold” rating in a research report on Wednesday, June 17th. Finally, Maxim Group cut their price target on Oxbridge Re from $5.00 to $3.00 and set a “buy” rating for the company in a report on Tuesday, June 16th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Oxbridge Re currently has a consensus rating of “Hold” and an average price target of $3.00.

About Oxbridge Re

Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.